|
Name |
methyl 8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate
|
Molecular Formula | C16H12O5 | |
IUPAC Name* |
methyl 8-hydroxy-6-methyl-9-oxoxanthene-1-carboxylate
|
|
SMILES |
CC1=CC(=C2C(=C1)OC3=CC=CC(=C3C2=O)C(=O)OC)O
|
|
InChI |
InChI=1S/C16H12O5/c1-8-6-10(17)14-12(7-8)21-11-5-3-4-9(16(19)20-2)13(11)15(14)18/h3-7,17H,1-2H3
|
|
InChIKey |
YEKIIDIQOZQXAX-UHFFFAOYSA-N
|
|
Synonyms |
methyl 8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate; CHEBI:68226; MEGxm0_000516; CHEMBL1812027; ACon1_001729; NCGC00180199-01; methyl 8-hydroxy-6-methyl-9-oxoxanthene-1-carboxylate; Q27136719; 1-Hydroxy-8-(methoxycarbonyl)-3-methyl-9H-xanthene-9-one
|
|
CAS | NA | |
PubChem CID | 11098071 | |
ChEMBL ID | CHEMBL1812027 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.26 | ALogp: | 3.4 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 72.8 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.546 |
Caco-2 Permeability: | -4.796 | MDCK Permeability: | 0.00002020 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.301 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.879 |
Blood-Brain-Barrier Penetration (BBB): | 0.099 | Plasma Protein Binding (PPB): | 88.86% |
Volume Distribution (VD): | 0.673 | Fu: | 8.97% |
CYP1A2-inhibitor: | 0.971 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.884 | CYP2C19-substrate: | 0.102 |
CYP2C9-inhibitor: | 0.844 | CYP2C9-substrate: | 0.922 |
CYP2D6-inhibitor: | 0.712 | CYP2D6-substrate: | 0.674 |
CYP3A4-inhibitor: | 0.46 | CYP3A4-substrate: | 0.146 |
Clearance (CL): | 2.031 | Half-life (T1/2): | 0.582 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.066 |
Drug-inuced Liver Injury (DILI): | 0.918 | AMES Toxicity: | 0.518 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.462 |
Skin Sensitization: | 0.832 | Carcinogencity: | 0.059 |
Eye Corrosion: | 0.087 | Eye Irritation: | 0.973 |
Respiratory Toxicity: | 0.189 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005347 | 0.794 | D0K8KX | 0.341 | ||||
ENC002469 | 0.776 | D0G5UB | 0.326 | ||||
ENC001749 | 0.710 | D06GCK | 0.323 | ||||
ENC002462 | 0.710 | D0H2ZW | 0.322 | ||||
ENC004885 | 0.701 | D04AIT | 0.318 | ||||
ENC002283 | 0.701 | D0Z3DY | 0.308 | ||||
ENC003136 | 0.681 | D0Y7PG | 0.287 | ||||
ENC004886 | 0.589 | D0G7IY | 0.286 | ||||
ENC002284 | 0.589 | D0W7WC | 0.283 | ||||
ENC002197 | 0.577 | D07MGA | 0.280 |